SaudiVax and MilliporeSigma team up to manufacture domestic vaccine for the Arabian peninsula
As Saudi Arabia works to get its domestically-produced vaccines into the arms of residents, it’s enlisted the help of Merck KGaA, Darmstadt, Germany to take on manufacturing duties.
MilliporeSigma, the US and Canadian life science division of Merck KGaA, Darmstadt, Germany, and SaudiVax will first conceptualize the process and determine the equipment needed before fitting out the facility and working out process development. SaudiVax employees will head to France to train at Merck’s end-to-end GMP site in Martillac, and its M Lab Collaboration Center in Mosheim.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.